[News] Source of stem cells in haploidentical transplantation

The use of peripheral blood stem cells (PBSCs) as the stem cell source in patients with acute leukaemia undergoing haploidentical transplantation with post-transplantation cyclophosphamide does not change survival outcomes but significantly increases the risk of acute graft-versus-host disease (GVHD) compared with transplantation using bone marrow, according to recent research.
Source: The Lancet Oncology - Category: Cancer & Oncology Authors: Tags: News Source Type: research